BIODANE PHARMA A/S: Financial statements 2014
CVR: 28310102
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 278,919 and a net result of DKK -250,379 compared with DKK -976,558 the year before. That is an increase of 162.5% compared with the year before. Equity in the 2014 report amounted to DKK 986,576. The solvency ratio was 89.5%.
- Gross Profit
- DKK 278,919
- Profit/Loss
- DKK -250,379
- Equity
- DKK 986,576
- Total Assets
- DKK 1,102,873
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
BIODANE PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 106,251, and the net result was DKK -976,558.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The board consists of Peter Gæmelke (chair), Flemming Torben Heden Knudsen, Gunner Kreutzer Jakobsen and Rasmus Juhl Rasmussen. The company is owned by BIODAN A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.